Osilodrostat - an emerging drug for the medical management of Cushing's disease.
Sign Up to like & getrecommendations! Published in 2022 at "Endokrynologia Polska"
DOI: 10.5603/ep.a2022.0009
Abstract: Cushing's disease (CD) is a rare endocrine disorder characterized by the overproduction of adrenocorticotropic hormone (ACTH) by pituitary adenoma followed by hypercortisolaemia with severe complications. Although transsphenoidal resection of the defined pituitary adenoma has been… read more here.
Keywords: disease osilodrostat; osilodrostat emerging; disease; management ... See more keywords